HeylandDMuscedereJWischmeyerPE. A randomized trial of glutamine and antioxidants in critically ill patients. N Engl J Med. 2013;368(16):1489-1497.
2.
van ZantenARSztarkFKaisersUX. High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial. JAMA. 2014;312(5):514-524.
3.
van ZantenARHofmanZHeylandDK. Consequences of the REDOXS and METAPLUS trials: the end of an era of glutamine and antioxidant supplementation for critically ill patients?JPEN J Parenter Enteral Nutr. 2015;39(8):890-892.
4.
VermeulenMABrinkmannSJStehlePvan LeeuwenPA. Consequences of the REDOXS and METAPLUS trials: the end of an era of glutamine and antioxidant supplementation for critically ill patients?JPEN J Parenter Enteral Nutr. 2016;40(1):12.
5.
van ZantenARHofmanZHeylandDK. Authors’ response to Vermeulen et al. JPEN J Parenter Enteral Nutr. 2016;40(1):12-13.
6.
WernermanJ. How to understand the results of studies of glutamine supplementation. Crit Care. 2015;19:385.
7.
PetterssonLRydenSSmedbergM. Validation of a point-of-care instrument for bedside glutamine screening in the intensive care unit [published online October28, 2015]. Clin Nutr.
